Colorectal cancer (CRC) is one of the most common cancer worldwide and results from the
accumulation of mutations and epimutations in colonic mucosa cells ultimately leading to …

Growing cancer incidence and mortality worldwide demands development of accurate
biomarkers to perfect detection, diagnosis, prognostication and monitoring. Urologic …

Background Methylated Septin9 (mSEPT9) has been suggested as a reliable biomarker in
colorectal cancer (CRC) detection. We aimed to determine the diagnostic value of mSEPT9 …

Background Colonoscopy is currently widely accepted as the gold standard for detection of
colorectal cancer (CRC) providing detection of up to 95% of pre-cancerous lesions during …

SEPT9 gene methylation has been implicated as a biomarker for colorectal cancer (CRC) for
more than 10 years and has been used clinically for more than 6 years. Studies have proven …

Diagnostic strategies, particularly non-invasive blood-based screening approaches, are
gaining increased attention for the early detection and attenuation of mortality associated …

Background The detection rate of methylated Septin9 (mSEPT9) in colorectal cancer (CRC)
is varied greatly across the studies. This study aimed to evaluate the diagnostic ability of …

Purpose Colorectal cancer (CRC) is one of the most common causes of cancer-related
death worldwide, and there is an urgent need to identify critical diagnostic and prognostic …

Purpose: In initial studies that included colorectal cancer patients undergoing diagnostic
colonoscopy, we had identified a serum marker combination able to detect colorectal cancer …

Biomarkers are biological molecules found in body fluids or tissues, which can be
considered as indications of a normal or abnormal process, or of a condition or disease …